Gender-dependent relationship between metabolic syndrome and HOMA-IR index in patients with impaired fasting glucose

Main Article Content

Nurhayat Ozkan Sevencan
Aysegul Ertinmaz Ozkan

Abstract

Aim: This study aimed to assess whether metabolic syndrome (MetS) criteria varied by gender and whether the homeostatic model assessment of insulin resistance (HOMA-IR) index could be used as a new MetS predictor. Materials and Methods: We performed a standard oral glucose tolerance test (OGTT) in 316 patients with impaired fasting glucose (IFG) and investigated the presence of impaired glucose tolerance (IGT), type 2 diabetes mellitus (T2DM), and MetS. Results: We found that MetS was higher in females than males. The obesity rate was 57.0% and 36.8% for females and males, respectively. Of the patients who reached stage 3 obesity,13.4% were females and 0.9% were males. The HOMA-IR score was not an independent predictor for MetS. However, sensitivity was 91% and specificity was 100% for the cut-off value of HOMA-IR ≥ 2.38 in diabetic females with MetS. Abdominal obesity (91.2%), hyperglycemia (81.5%), hypertension (71.8%), hypertriglyceridemia (62.0%), and low high-density lipoprotein (HDL) (57.8%) were found in MetS patients. Conclusion: Abdominal obesity and impaired glucose metabolism are powerful predictors demonstrating the presence of MetS. Females are at greater risk than males for obesity, T2DM, and MetS. Although the HOMA-IR score is not a new MetS predictor, it may be an effective indicator of the combination of MetS and diabetes in females.

Downloads

Download data is not yet available.

Article Details

How to Cite
Ozkan Sevencan, N., & Ertinmaz Ozkan, A. (2021). Gender-dependent relationship between metabolic syndrome and HOMA-IR index in patients with impaired fasting glucose . Annals of Medical Research, 28(2), 0410–0416. Retrieved from http://annalsmedres.org/index.php/aomr/article/view/372
Section
Original Articles